 Patrick Carry
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 11 | 2023 | 178 | 3.410 |
Why?
| | Acetabulum | 16 | 2023 | 91 | 1.730 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 37 | 1.670 |
Why?
| | DNA Methylation | 5 | 2021 | 493 | 1.480 |
Why?
| | Islets of Langerhans | 4 | 2023 | 728 | 1.290 |
Why?
| | Spinal Fusion | 6 | 2022 | 199 | 1.190 |
Why?
| | Humeral Fractures | 8 | 2022 | 46 | 1.180 |
Why?
| | Fractures, Bone | 8 | 2023 | 367 | 1.090 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 206 | 1.030 |
Why?
| | Autoimmunity | 6 | 2023 | 812 | 0.940 |
Why?
| | Hip Joint | 11 | 2022 | 124 | 0.940 |
Why?
| | Hip Dislocation | 8 | 2023 | 44 | 0.930 |
Why?
| | Adolescent | 58 | 2023 | 17800 | 0.910 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2023 | 3254 | 0.870 |
Why?
| | Propensity Score | 3 | 2023 | 225 | 0.840 |
Why?
| | Child | 59 | 2023 | 18400 | 0.820 |
Why?
| | Kyphosis | 1 | 2022 | 33 | 0.790 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 82 | 0.780 |
Why?
| | Osteotomy | 10 | 2017 | 143 | 0.780 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 114 | 0.780 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 10 | 0.750 |
Why?
| | Radiography | 21 | 2021 | 803 | 0.750 |
Why?
| | Genome-Wide Association Study | 3 | 2021 | 1176 | 0.730 |
Why?
| | Seroconversion | 1 | 2021 | 45 | 0.730 |
Why?
| | Postoperative Complications | 18 | 2020 | 2122 | 0.700 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 210 | 0.700 |
Why?
| | Diseases in Twins | 1 | 2021 | 174 | 0.700 |
Why?
| | Semicircular Canals | 1 | 2020 | 28 | 0.680 |
Why?
| | Retrospective Studies | 52 | 2023 | 12521 | 0.680 |
Why?
| | Phospholipids | 1 | 2021 | 194 | 0.660 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 32 | 0.660 |
Why?
| | Ultrasonography | 6 | 2022 | 635 | 0.630 |
Why?
| | Surgeons | 1 | 2022 | 236 | 0.620 |
Why?
| | Humans | 100 | 2023 | 114043 | 0.610 |
Why?
| | Upper Extremity | 2 | 2023 | 83 | 0.610 |
Why?
| | Health Status | 1 | 2023 | 716 | 0.590 |
Why?
| | Joint Instability | 6 | 2022 | 163 | 0.590 |
Why?
| | Algorithms | 2 | 2023 | 1469 | 0.570 |
Why?
| | Fracture Fixation | 3 | 2015 | 75 | 0.560 |
Why?
| | Athletic Injuries | 6 | 2022 | 456 | 0.530 |
Why?
| | Female | 68 | 2023 | 59325 | 0.530 |
Why?
| | Femur | 5 | 2023 | 191 | 0.530 |
Why?
| | Arteries | 1 | 2018 | 246 | 0.520 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 53 | 0.520 |
Why?
| | Male | 68 | 2023 | 55396 | 0.510 |
Why?
| | Tibial Fractures | 3 | 2023 | 67 | 0.490 |
Why?
| | Clavicle | 3 | 2014 | 30 | 0.490 |
Why?
| | Pain, Postoperative | 5 | 2018 | 190 | 0.480 |
Why?
| | Child, Preschool | 18 | 2021 | 9114 | 0.470 |
Why?
| | Lower Extremity | 3 | 2023 | 334 | 0.460 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 130 | 0.450 |
Why?
| | Treatment Outcome | 31 | 2023 | 9049 | 0.440 |
Why?
| | Femur Head | 3 | 2021 | 31 | 0.440 |
Why?
| | Return to Sport | 5 | 2022 | 80 | 0.430 |
Why?
| | Oxylipins | 3 | 2023 | 27 | 0.410 |
Why?
| | Snow Sports | 1 | 2012 | 2 | 0.400 |
Why?
| | Head Protective Devices | 1 | 2012 | 14 | 0.400 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 7 | 0.400 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 194 | 0.390 |
Why?
| | Case-Control Studies | 8 | 2023 | 3003 | 0.380 |
Why?
| | Insulin | 2 | 2021 | 2080 | 0.370 |
Why?
| | Epiphyses | 7 | 2021 | 17 | 0.360 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.360 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.350 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 8 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3039 | 0.350 |
Why?
| | Bone Nails | 4 | 2019 | 58 | 0.340 |
Why?
| | Brain Concussion | 3 | 2022 | 477 | 0.340 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 13 | 0.340 |
Why?
| | Parent-Child Relations | 1 | 2012 | 235 | 0.340 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2537 | 0.320 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 7 | 0.320 |
Why?
| | Clubfoot | 2 | 2019 | 10 | 0.290 |
Why?
| | Casts, Surgical | 2 | 2019 | 28 | 0.290 |
Why?
| | Disease Progression | 4 | 2022 | 2371 | 0.280 |
Why?
| | Prevalence | 4 | 2022 | 2247 | 0.270 |
Why?
| | Cohort Studies | 8 | 2021 | 4883 | 0.270 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 6 | 0.270 |
Why?
| | Sports | 2 | 2022 | 187 | 0.270 |
Why?
| | Spine | 2 | 2018 | 136 | 0.270 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 246 | 0.270 |
Why?
| | Risk Factors | 15 | 2023 | 8614 | 0.260 |
Why?
| | Cadaver | 3 | 2022 | 298 | 0.260 |
Why?
| | Clinical Protocols | 2 | 2018 | 232 | 0.260 |
Why?
| | Infant | 13 | 2023 | 7943 | 0.260 |
Why?
| | Athletes | 5 | 2022 | 328 | 0.250 |
Why?
| | Young Adult | 15 | 2022 | 10444 | 0.250 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 19 | 0.250 |
Why?
| | Tibia | 2 | 2023 | 166 | 0.230 |
Why?
| | Range of Motion, Articular | 7 | 2022 | 350 | 0.230 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 43 | 0.230 |
Why?
| | Biomechanical Phenomena | 6 | 2022 | 669 | 0.230 |
Why?
| | Elbow Joint | 3 | 2019 | 59 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2020 | 286 | 0.230 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 9 | 0.230 |
Why?
| | Time Factors | 13 | 2021 | 6077 | 0.230 |
Why?
| | Odds Ratio | 8 | 2019 | 951 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2272 | 0.220 |
Why?
| | Orthotic Devices | 3 | 2022 | 28 | 0.220 |
Why?
| | Reoperation | 6 | 2017 | 513 | 0.220 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 76 | 0.220 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 79 | 0.210 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 517 | 0.210 |
Why?
| | Growth Plate | 2 | 2023 | 32 | 0.210 |
Why?
| | Humerus | 2 | 2022 | 40 | 0.210 |
Why?
| | Adult | 18 | 2023 | 30375 | 0.210 |
Why?
| | Meniere Disease | 1 | 2023 | 30 | 0.210 |
Why?
| | Ligaments, Articular | 1 | 2022 | 54 | 0.200 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 41 | 0.200 |
Why?
| | Wrist Joint | 1 | 2022 | 59 | 0.200 |
Why?
| | Hip Fractures | 1 | 2023 | 75 | 0.200 |
Why?
| | Spinal Fractures | 1 | 2023 | 74 | 0.200 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 19 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 82 | 0.190 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 104 | 0.190 |
Why?
| | Radius Fractures | 1 | 2022 | 56 | 0.190 |
Why?
| | Ankle Fractures | 1 | 2022 | 18 | 0.190 |
Why?
| | Age Factors | 7 | 2021 | 2885 | 0.190 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 1 | 0.190 |
Why?
| | Bone Plates | 2 | 2022 | 75 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 77 | 0.190 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.190 |
Why?
| | Selection Bias | 1 | 2021 | 33 | 0.190 |
Why?
| | Follow-Up Studies | 10 | 2021 | 4392 | 0.190 |
Why?
| | Incidence | 8 | 2023 | 2314 | 0.190 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.180 |
Why?
| | Cerebral Palsy | 1 | 2022 | 80 | 0.180 |
Why?
| | Neck Muscles | 1 | 2021 | 15 | 0.180 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 13 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2023 | 126 | 0.180 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 207 | 0.180 |
Why?
| | Suture Techniques | 2 | 2019 | 115 | 0.180 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 38 | 0.180 |
Why?
| | Probability | 1 | 2021 | 286 | 0.180 |
Why?
| | Arthralgia | 2 | 2020 | 46 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1078 | 0.170 |
Why?
| | Muscle Strength | 2 | 2021 | 271 | 0.170 |
Why?
| | Bias | 1 | 2021 | 178 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 133 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2001 | 120 | 0.170 |
Why?
| | Patella | 1 | 2019 | 22 | 0.170 |
Why?
| | Recreation | 1 | 2019 | 20 | 0.170 |
Why?
| | Play and Playthings | 1 | 2019 | 30 | 0.170 |
Why?
| | Histology | 1 | 2019 | 3 | 0.160 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 11 | 0.160 |
Why?
| | Education, Professional | 1 | 2019 | 19 | 0.160 |
Why?
| | Health Occupations | 1 | 2019 | 28 | 0.160 |
Why?
| | Gene Frequency | 1 | 2020 | 476 | 0.160 |
Why?
| | Equipment Failure | 1 | 2019 | 107 | 0.160 |
Why?
| | Logistic Models | 5 | 2017 | 1829 | 0.150 |
Why?
| | Tendons | 1 | 2019 | 118 | 0.150 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 59 | 0.150 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 86 | 0.150 |
Why?
| | Interleukins | 1 | 2020 | 236 | 0.150 |
Why?
| | Genetic Association Studies | 1 | 2020 | 339 | 0.150 |
Why?
| | Anesthesia, Local | 1 | 2018 | 14 | 0.150 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 8 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 25 | 0.150 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 304 | 0.150 |
Why?
| | Autoantibodies | 2 | 2022 | 1347 | 0.150 |
Why?
| | Femoral Nerve | 1 | 2018 | 15 | 0.150 |
Why?
| | Bone Malalignment | 1 | 2017 | 14 | 0.150 |
Why?
| | Arthroscopy | 2 | 2020 | 199 | 0.150 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 20 | 0.150 |
Why?
| | Meningomyelocele | 1 | 2018 | 54 | 0.150 |
Why?
| | Collagen | 1 | 2020 | 414 | 0.150 |
Why?
| | Sciatic Nerve | 1 | 2018 | 56 | 0.140 |
Why?
| | Femoral Fractures | 1 | 2018 | 64 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 95 | 0.140 |
Why?
| | Nerve Block | 1 | 2018 | 60 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 385 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2022 | 720 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 511 | 0.130 |
Why?
| | Prospective Studies | 7 | 2023 | 6195 | 0.130 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 29 | 0.130 |
Why?
| | Learning Curve | 1 | 2017 | 63 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4402 | 0.130 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.130 |
Why?
| | Metabolomics | 1 | 2021 | 511 | 0.130 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 24 | 0.130 |
Why?
| | Pain | 1 | 2022 | 701 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 50 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 74 | 0.130 |
Why?
| | Electrocardiography | 2 | 2016 | 561 | 0.130 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1791 | 0.130 |
Why?
| | Radius | 1 | 2015 | 33 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2090 | 0.120 |
Why?
| | Caregivers | 1 | 2022 | 713 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2015 | 12 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 331 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1175 | 0.120 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 150 | 0.120 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 31 | 0.120 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 68 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 237 | 0.120 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 34 | 0.120 |
Why?
| | Long QT Syndrome | 1 | 2015 | 59 | 0.120 |
Why?
| | Obesity | 3 | 2015 | 2505 | 0.120 |
Why?
| | Diet | 1 | 2021 | 1080 | 0.120 |
Why?
| | Menisci, Tibial | 1 | 2014 | 53 | 0.120 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 44 | 0.120 |
Why?
| | Autografts | 1 | 2014 | 40 | 0.120 |
Why?
| | Patient Compliance | 1 | 2018 | 524 | 0.110 |
Why?
| | Bone Diseases | 1 | 2014 | 57 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2016 | 141 | 0.110 |
Why?
| | Risk Assessment | 7 | 2017 | 2958 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 121 | 0.110 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 180 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2015 | 116 | 0.110 |
Why?
| | Body Mass Index | 3 | 2016 | 1957 | 0.110 |
Why?
| | Clinical Competence | 2 | 2017 | 882 | 0.110 |
Why?
| | Joint Dislocations | 1 | 2014 | 57 | 0.110 |
Why?
| | Cartilage | 1 | 2015 | 182 | 0.110 |
Why?
| | United States | 9 | 2022 | 12137 | 0.110 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 48 | 0.110 |
Why?
| | Injury Severity Score | 3 | 2023 | 472 | 0.110 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 492 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1880 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 982 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 215 | 0.100 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.100 |
Why?
| | Bupivacaine | 1 | 2012 | 31 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 813 | 0.100 |
Why?
| | Knee Joint | 3 | 2022 | 322 | 0.100 |
Why?
| | Graft Survival | 1 | 2014 | 443 | 0.100 |
Why?
| | Amides | 1 | 2012 | 87 | 0.100 |
Why?
| | Bone and Bones | 1 | 2014 | 277 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1422 | 0.100 |
Why?
| | Treatment Failure | 3 | 2019 | 330 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 489 | 0.090 |
Why?
| | CpG Islands | 2 | 2021 | 118 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2764 | 0.090 |
Why?
| | Recovery of Function | 4 | 2016 | 573 | 0.090 |
Why?
| | Operative Time | 3 | 2017 | 106 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6306 | 0.090 |
Why?
| | Linear Models | 3 | 2021 | 768 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 771 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 133 | 0.090 |
Why?
| | North America | 1 | 2011 | 255 | 0.090 |
Why?
| | Sex Factors | 3 | 2021 | 1706 | 0.080 |
Why?
| | Mice | 2 | 2023 | 14841 | 0.080 |
Why?
| | Trauma Centers | 2 | 2022 | 347 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2016 | 581 | 0.080 |
Why?
| | Torque | 2 | 2021 | 66 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 618 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2087 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 89 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1471 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 541 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 29 | 0.080 |
Why?
| | Postoperative Care | 3 | 2015 | 223 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 132 | 0.070 |
Why?
| | Observer Variation | 2 | 2018 | 298 | 0.070 |
Why?
| | Regression Analysis | 2 | 2019 | 945 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 97 | 0.070 |
Why?
| | Patient Care Team | 1 | 2010 | 517 | 0.060 |
Why?
| | Equipment Design | 2 | 2019 | 503 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2019 | 5038 | 0.060 |
Why?
| | Hemodilution | 2 | 1996 | 9 | 0.060 |
Why?
| | Prognosis | 3 | 2020 | 3315 | 0.060 |
Why?
| | Animals | 2 | 2023 | 31565 | 0.060 |
Why?
| | Middle Aged | 7 | 2022 | 26605 | 0.060 |
Why?
| | Knee Injuries | 2 | 2015 | 88 | 0.060 |
Why?
| | Pain Measurement | 2 | 2018 | 441 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4090 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 30 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 37 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 571 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 110 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 89 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 265 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 126 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 75 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 3 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 64 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 64 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 57 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 62 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 3 | 0.050 |
Why?
| | Chin | 1 | 2001 | 5 | 0.050 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.050 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 11 | 0.050 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 10 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 37 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 58 | 0.050 |
Why?
| | Malocclusion | 1 | 2001 | 23 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 21 | 0.050 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 11 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2021 | 112 | 0.050 |
Why?
| | Work | 1 | 2020 | 17 | 0.050 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1815 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 69 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2001 | 44 | 0.050 |
Why?
| | Musculoskeletal System | 1 | 2021 | 42 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 160 | 0.040 |
Why?
| | Blood | 1 | 2001 | 94 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 45 | 0.040 |
Why?
| | Gait | 1 | 2022 | 250 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 54 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 268 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 196 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 408 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 93 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 22 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 46 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 465 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 156 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 742 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 45 | 0.040 |
Why?
| | Radiation Dosage | 1 | 2020 | 133 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 50 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 122 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 410 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 23 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 51 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1447 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 81 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 366 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 79 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 141 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 328 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 68 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 89 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1089 | 0.040 |
Why?
| | Organ Size | 1 | 2018 | 434 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 123 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 217 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1125 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 444 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 11 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 18 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 48 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 29 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 106 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1381 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 122 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 39 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 80 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 288 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 273 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 33 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 72 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 175 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 37 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 110 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 9 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 285 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 153 | 0.030 |
Why?
| | Skull | 1 | 1996 | 119 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 7 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 108 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 441 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 74 | 0.030 |
Why?
| | Edema | 1 | 1995 | 119 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 1762 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 421 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 74 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 221 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 341 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 42 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 336 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 66 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 38 | 0.030 |
Why?
| | Face | 1 | 1995 | 163 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 319 | 0.030 |
Why?
| | Self Report | 1 | 2016 | 695 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 41 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 445 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2343 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2012 | 81 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 259 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 556 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1024 | 0.020 |
Why?
| | Communication | 1 | 2016 | 734 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 629 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 944 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 714 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1218 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 478 | 0.020 |
Why?
| | Lung | 1 | 2001 | 3521 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1836 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4595 | 0.020 |
Why?
| | Aged | 2 | 2022 | 18969 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 472 | 0.020 |
Why?
| | Length of Stay | 1 | 2010 | 957 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 62 | 0.020 |
Why?
| | Inflammation | 1 | 1996 | 2464 | 0.020 |
Why?
| | Orosomucoid | 1 | 1995 | 5 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 36 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 47 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 57 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 86 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 59 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 277 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 122 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 104 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 143 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 362 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 196 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|